$4.04
-0.0500 (-1.22%)
At Close: Jun 03, 2026
Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results
05:00pm, Monday, 23'rd Mar 2026
Daix (France), New York (United States), March 23, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on th
Inventiva S.A. (IVA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
04:32pm, Wednesday, 11'th Mar 2026
Inventiva S.A. (IVA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Does Inventiva (IVA) Have the Potential to Rally 136.34% as Wall Street Analysts Expect?
10:55am, Friday, 27'th Feb 2026
The mean of analysts' price targets for Inventiva (IVA) points to a 136.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analys
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives Consensus Recommendation of “Buy” from Analysts
02:08am, Wednesday, 18'th Feb 2026
Shares of Inventiva S.A. Sponsored ADR (NASDAQ: IVA - Get Free Report) have earned an average recommendation of "Buy" from the ten research firms that are presently covering the company, MarketBeat re
Inventiva reports preliminary 2025¹ fiscal year financial results
02:30am, Tuesday, 17'th Feb 2026
Daix (France), New York City (New York, United States) , February 17, 2026 – Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company foc
Comparing Vera Therapeutics (NASDAQ:VERA) & Inventiva (NASDAQ:IVA)
01:18am, Thursday, 05'th Feb 2026
Inventiva (NASDAQ: IVA - Get Free Report) and Vera Therapeutics (NASDAQ: VERA - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on t
Inventiva to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
04:00pm, Wednesday, 04'th Feb 2026
Daix (France), New York (United States), February 4, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on
Biotech Inventiva's 50% surge shows investor optimism over liver disease drug
10:39am, Wednesday, 28'th Jan 2026
A surge in Inventiva shares, up about 50% in the first few weeks of 2026, highlights investors' appetite for betting on the loss-making French biotech, which is on the verge of entering the fast-gr
Are You Looking for a Top Momentum Pick? Why Inventiva S.A.
01:00pm, Monday, 26'th Jan 2026
Does Inventiva S.A. Sponsored ADR (IVA) have what it takes to be a top stock pick for momentum investors?
Inventiva S.A. (IVA) Presents at 44th Annual J.P.
02:16pm, Thursday, 15'th Jan 2026
Inventiva S.A. (IVA) Presents at 44th Annual J.P.
Wall Street Analysts Predict a 200.59% Upside in Inventiva (IVA): Here's What You Should Know
10:56am, Thursday, 08'th Jan 2026
The consensus price target hints at a 200.6% upside potential for Inventiva (IVA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimat
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Rating of “Moderate Buy” by Brokerages
03:18am, Tuesday, 30'th Dec 2025
Inventiva S.A. Sponsored ADR (NASDAQ: IVA - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven ratings firms that are presently covering the firm, MarketBeat.com rep
Inventiva reports 2025 Third Quarter Financial Information¹
04:00pm, Friday, 21'st Nov 2025
Daix (France), New York City, (New York, United States), November 21, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company foc
Inventiva announces full exercise of Underwriters' Option, bringing proceeds of Offering to approximately $172.5M
02:30am, Monday, 17'th Nov 2025
Daix (France), New York City (New York, United States), November 17, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focu
Wall Street Week Ahead
07:05am, Sunday, 16'th Nov 2025
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Sign In
Buy IVA